MedTrace Logo

Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease

NCT00090402 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2017-07-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effect of fish oil and the antioxidant alpha lipoic acid on factors in the blood that are associated with the progression of Alzheimer's Disease (AD).

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish Oil

Fish oil capsule

DIETARY_SUPPLEMENT

Lipoic Acid

Lipoic acid capsule

OTHER

Fish Oil Placebo

Soybean oil placebo capsule

OTHER

Lipoic Acid Placebo

Lipoic acid (LA) placebo capsule containing no LA

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Lynne H. Shinto, ND · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2006-01-03
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00090402 on ClinicalTrials.gov